Tony Coles

There are two people named Tony Coles, one who works for iHeartMedia and another who works in the medical field.

Tony Coles, President at Black Information Network (BIN) and iHeartMedia: Tony Coles is the President of the Black Information Network (BIN) and Division President of Metro Markets for iHeartMedia.4 In his role as President of Multi-Cultural Business and Development, Coles works across iHeartMedia to support and grow multicultural audiences and revenue.1 He connects Hispanic, Black, AANHPI, and LGBTQIA+ consumers and clients with iHeartMedia.1 Coles has over 35 years of experience in the radio industry.6

Experience and Roles::

• President of Black Information Network (BIN) at iHeartMedia: Coles has held this position since June 2020.3 BIN is the first and only 24/7 comprehensive national audio news service dedicated to providing continual news coverage with a Black voice and perspective.16
• Division President - Markets Group at iHeartMedia: Coles has held this position since January 2020.3
• Executive Vice President of Programming at iHeartMedia: From 2016 to 2020, Coles was the Executive Vice President of Programming for iHeartMedia’s Western US markets.3
• Other Roles at iHeartMedia: Senior Vice President of Programming for Alaska, Hawaii, and the Pacific Northwest; Operations Manager of the Chicago region.3 Earlier in his career, he held programming leadership and management positions for a diverse array of formats and markets including New York, Los Angeles, Seattle, Portland, and Columbus, Ohio.3
• Additional Boards: Coles serves as Vice Chair on the Big Brothers Big Sisters of America board of directors, and on the boards for the National Association of Broadcasters Leadership Foundation, the Radio Advertising Bureau, and The Conclave.3

Education::

• Marylhurst University: Bachelor of Arts in Communications3
• Western Governors University School of Business: MBA3

Tony Coles, MD, Chair, Board of Directors, Cerevel Therapeutics: N. Anthony Coles, MD, has served as chair of the board of directors for Cerevel Therapeutics since 2018.2 He was CEO of Cerevel from September 2019 to June 2023.2

Current Roles::

• Chair, Board of Directors, Cerevel Therapeutics: Coles has served in this role since 2018.2
• Chair and CEO of TRATE Enterprises: He has held this position in the privately-held company since 2013.5
• Board of Directors of Regeneron Pharmaceuticals, Inc.: Coles has been a director since 2017.5
• Council Chair for the Smithsonian Museum of African American History and Culture2
• Board of Trustees of the Metropolitan Museum of Art2
• Board of Directors on the Council on Foreign Relations2

Past Experience::

• CEO of Yumanity Therapeutics2
• President, CEO, and Chair of the Board of Onyx Pharmaceuticals, Inc.2
• President, CEO, and Member of the Board of Directors at NPS Pharmaceuticals, Inc.2
• Executive positions at Bristol-Myers Squibb and Merck & Co, Inc.2
• Senior Vice President of Commercial Operations at Vertex Pharmaceuticals, Inc.2
• Former director of CRISPR Therapeutics AG; Laboratory Corporation of America Holdings; Campus Crest Communities, Inc.; and McKesson Corporation.2

Education::

• Johns Hopkins2
• Duke University School of Medicine2
• Harvard University2

Training::

• Massachusetts General Hospital2
• Harvard Medical School2